Army backs further development of rapid transfusion-transmitted disease tests

10/21/2013 | Genetic Engineering & Biotechnology News

An Army contract worth an additional $1.917 million will support MedMira's continued development of the Reveal Rapid Hepatitis B Surface Antigen Test and Multiplo Rapid HBc/HIV/HCV Antibody Test. The tests are being developed for frontline military medical uses, plus humanitarian and disaster relief efforts, according to MedMira.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ